{"id":20100,"date":"2020-06-25T15:22:16","date_gmt":"2020-06-25T13:22:16","guid":{"rendered":"https:\/\/www.satt.fr\/satt-up-juin-2020\/"},"modified":"2020-06-25T15:41:14","modified_gmt":"2020-06-25T13:41:14","slug":"satt-up-juin-2020","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020"},"content":{"rendered":"
\n
\n\t

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT\u00a0: Lev\u00e9e de fonds, d\u00e9veloppement, \u00e9v\u00e9nement internationaux...\u00a0<\/strong>Le R\u00e9seau SATT c'est 493 start-up Deep Tech #SATTUP !<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div>

\t\t\t

InBrain Pharma\u00a0obtient l’accord de l\u2019ANSM pour sa demande D\u2019essai clinique<\/strong> (SATT Nord)<\/em><\/p>\n

InBrain Pharma, start-up lilloise de biotechnologie d\u00e9veloppant des solutions th\u00e9rapeutiques contre les maladies du cerveau, re\u00e7oit l\u2019autorisation de l\u2019Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament (ANSM) de traiter avec sa technologie DIVE (Dopamine IntracerebroVentriculairE) des premiers patients atteints de la maladie de Parkinson (\u00e9tude de phase I\/IIb).<\/p>\n

www.inbrainpharma.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Signia Therapeutics obtient un financement europ\u00e9en qui vient consacrer des \u00e9tapes majeures franchies et acc\u00e9l\u00e9rer\u00a0le d\u00e9veloppement de sa plateforme Signatura<\/b> (PULSALYS)<\/em><\/p>\n

Signia Therapeutics a annonc\u00e9 aujourd\u2019hui l\u2019obtention d\u2019une subvention d\u2019un montant de 2,38M\u20ac de la Commission Europ\u00e9enne dans le cadre de l\u2019appel \u00e0 projets \u00ab EIC Accelerator Phase 2 \u00bb (Instrument SME), pour le d\u00e9veloppement de sa plateforme SIGNATURA\u00ae d\u00e9di\u00e9e au repositionnement de m\u00e9dicaments.<\/p>\n

signiatherapeutics.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

La start-up brestoise KALSIOM boucle son premier tour de financement de 2 millions<\/strong> (Ouest Valorisation)<\/em><\/p>\n

La start-up brestoise KALSIOM boucle son premier tour de financement de 2 millions d’euros aupr\u00e8s de GO CAPITAL, d’Advent France Biotechnology et de la SATT Ouest Valorisation.Cr\u00e9\u00e9e en avril 2020, la jeune pousse KALSIOM, soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise, vise le d\u00e9veloppement de nouveaux anticorps immuno-modulateurs \u00ab First in Class \u00bb ciblant la r\u00e9gulation de la signalisation calcique pour le traitement de certaines maladies auto-immunes.<\/p>\n

www.ouest-valorisation.fr\/kalsiom<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Kurage, la mobilit\u00e9 retrouv\u00e9e, rendre le sport accessible \u00e0 tous<\/strong> (PULSALYS)<\/em><\/p>\n

Rendre la mobilit\u00e9 \u00e0 ceux qui l\u2019ont partiellement ou compl\u00e8tement perdue, leur permettre de (re)pratiquer une activit\u00e9 sportive et physique de mani\u00e8re simple, ludique et autonome via une solution bas\u00e9e sur la remobilisation neuromusculaire par \u00e9lectrostimulation… c\u2019est le tr\u00e8s beau challenge de Kurage, une startup lyonnaise, soutenue par PULSALYS.<\/p>\n

kurage.fr<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Dynacure Announces \u20ac50M ($55M) Series C Financing<\/strong> (Conectus)<\/em><\/p>\n

Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today the close of a \u20ac50 million Series C financing led by Perceptive Advisors. New investors participating in this financing include Bpifrance Large Venture and funds managed by Tekla Capital Management LLC. Dynacure\u2019s existing investors Andera Partners, Bpifrance through its FABS and Fonds Bioth\u00e9rapies Innovantes et Maladies Rares funds , Kurma Partners and Pontifax also meaningfully participated. In connection with the financing, Henry<\/p>\n

www.dynacure.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Alice&Bob l\u00e8ve 3M\u20ac et entre dans la course \u00e0 l\u2019ordinateur quantique<\/strong> (PULSALYS)<\/em><\/p>\n

Devenir le principal fournisseur de puissance de calcul quantique au moyen d\u2019un ordinateur quantique universel sans erreur, telle est l\u2019ambition d\u2019Alice&Bob. Une ambition soutenue par Elaia et Breega avec qui Alice&Bob conclut aujourd\u2019hui sa premi\u00e8re lev\u00e9e de fonds de trois millions d\u2019euros afin d’acc\u00e9l\u00e9rer la construction de son prototype.<\/p>\n

www.pulsalys.fr\/startup\/alicebob<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

TreeFrog Therapeutics ouvre son premier site industriel \u00e0 Pessac (33), d\u00e9di\u00e9 aux th\u00e9rapies cellulaires issues de cellules souches\u00a0<\/strong>(Aquitaine Science Transfert)<\/em><\/p>\n

TreeFrog Therapeutics annonce aujourd’hui la mise en service d’un premier site industriel de 1200m\u00b2 \u00e0 Pessac (33), d\u00e9di\u00e9 au d\u00e9veloppement et \u00e0 la production de th\u00e9rapies cellulaires issues de cellules souches pluripotentes induites (CSPi). Fond\u00e9e sur la technologie propri\u00e9taire C-StemTM, cette plateforme industrielle de culture cellulaire en 3D vise \u00e0 produire des th\u00e9rapies cellulaires en masse, en divisant les co\u00fbts de production par 10.<\/p>\n

treefrog.fr<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Une nouvelle technologie pour le traitement des complications li\u00e9es au Covid-19<\/strong> (PULSALYS)<\/em><\/p>\n

Suite \u00e0 des essais animaux concluants sur sa capacit\u00e9 \u00e0 capter s\u00e9lectivement des m\u00e9taux dans le sang, MexBrain poursuit son d\u00e9veloppement vers une des maladies les plus mortelles, la septic\u00e9mie. Le 5 Mai 2020, la soci\u00e9t\u00e9 MexBrain a d\u00e9pos\u00e9 un nouveau brevet pour le traitement de la septic\u00e9mie par captation s\u00e9lective des m\u00e9taux au moyen d\u2019un dispositif de dialyse associ\u00e9 \u00e0 un fluide collo\u00efdal.<\/p>\n

mexbrain.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Find Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal <\/strong>(Conectus)<\/em><\/p>\n

CTI Life Sciences, along with partners adMare BioInnovations, Domain Therapeutics and PeptiMimesis Pharma, have come together to establish a new Montreal-based drug discovery and development company, Find Therapeutics, dedicated to the development of the next generation of GPCR allosteric modulators to treat rare diseases.<\/p>\n

www.domaintherapeutics.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Carbon Waters et Certis Therapeutics, s\u00e9lectionn\u00e9es pour participer \u00e0 l\u2019\u00e9dition 2020 du programme Deeptech North America \u2013 NETVA. <\/strong>(Aquitaine Science Transfert)<\/em><\/p>\n

14 start-up innovantes fran\u00e7aises viennent d\u2019\u00eatre s\u00e9lectionn\u00e9es pour participer \u00e0 l\u2019\u00e9dition 2020 du programme Deeptech North America \u2013 NETVA port\u00e9 par le minist\u00e8re de l\u2019Europe et des Affaires Etrang\u00e8res. Ce programme d\u2019accompagnement personnalis\u00e9, d\u2019analyse d\u2019opportunit\u00e9s et de d\u00e9veloppement de partenariats technologiques aux Etats-Unis, est d\u00e9di\u00e9 aux jeunes start-up innovantes fran\u00e7aises, souhaitant se pr\u00e9parer aux r\u00e9alit\u00e9s et sp\u00e9cificit\u00e9s des march\u00e9s nord-am\u00e9ricains pour r\u00e9ussir leur internationalisation.<\/p>\n

www.carbon-waters.com<\/a>\u00a0certis-therapeutics.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div>
\t\t\t

Vaxxel s\u00e9lectionn\u00e9e pour participer \u00e0 l\u2019\u00e9dition 2020 du programme Deeptech North America \u2013 NETVA.\u00a0<\/strong>(PULSALYS)<\/em><\/p>\n

14 start-up innovantes fran\u00e7aises viennent d\u2019\u00eatre s\u00e9lectionn\u00e9es pour participer \u00e0 l\u2019\u00e9dition 2020 du programme Deeptech North America \u2013 NETVA port\u00e9 par le minist\u00e8re de l\u2019Europe et des Affaires Etrang\u00e8res. Ce programme d\u2019accompagnement personnalis\u00e9, d\u2019analyse d\u2019opportunit\u00e9s et de d\u00e9veloppement de partenariats technologiques aux Etats-Unis, est d\u00e9di\u00e9 aux jeunes start-up innovantes fran\u00e7aises, souhaitant se pr\u00e9parer aux r\u00e9alit\u00e9s et sp\u00e9cificit\u00e9s des march\u00e9s nord-am\u00e9ricains pour r\u00e9ussir leur internationalisation.<\/p>\n

www.pulsalys.fr\/startup\/vaxxel<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div>

\"\"<\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les membres du R\u00e9seau SATT\u00a0: Lev\u00e9e de fonds, d\u00e9veloppement, \u00e9v\u00e9nement internationaux…\u00a0Le R\u00e9seau SATT c’est 493 start-up Deep Tech #SATTUP ! InBrain Pharma\u00a0obtient l’accord de l\u2019ANSM pour sa demande D\u2019essai clinique (SATT Nord) InBrain Pharma, start-up lilloise de biotechnologie d\u00e9veloppant des solutions th\u00e9rapeutiques contre les maladies du cerveau, […]<\/p>\n","protected":false},"author":2,"featured_media":11835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[562],"tags":[],"class_list":["post-20100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-satt-network"],"acf":[],"yoast_head":"\nSATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020\",\"datePublished\":\"2020-06-25T13:22:16+00:00\",\"dateModified\":\"2020-06-25T13:41:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\"},\"wordCount\":1091,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"articleSection\":[\"SATT Network\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\",\"url\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"datePublished\":\"2020-06-25T13:22:16+00:00\",\"dateModified\":\"2020-06-25T13:41:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png\",\"width\":6399,\"height\":3569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020","datePublished":"2020-06-25T13:22:16+00:00","dateModified":"2020-06-25T13:41:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/"},"wordCount":1091,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","articleSection":["SATT Network"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/","url":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/","name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","datePublished":"2020-06-25T13:22:16+00:00","dateModified":"2020-06-25T13:41:14+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","width":6399,"height":3569},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-juin-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par le membres du R\u00e9seau SATT #19 \u2013 Juin 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=20100"}],"version-history":[{"count":4,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20100\/revisions"}],"predecessor-version":[{"id":20108,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20100\/revisions\/20108"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/11835"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=20100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=20100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=20100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}